<DOC>
	<DOCNO>NCT00721994</DOCNO>
	<brief_summary>primary endpoint Study maintenance `` least good clinical status '' period 10 year follow initial implantation among Cormet procedure enrol inthe pre-market IDE .</brief_summary>
	<brief_title>Post-PMA Approval Study : 10 Year Follow-Up IDE Subjects</brief_title>
	<detailed_description>Maintaining `` least good clinical status '' determine base upon composite clinical success ( CCS ) criterion include revision , removal , replacement device component Harris Hip Total score great equal 80 point .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteonecrosis</mesh_term>
	<criteria>subject enrol Cormet IDE study 5 identified clinical site Individuals agree participate study sign informed patient consent form</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hip resurface</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>avascular necrosis</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>